You have 9 free searches left this month | for more free features.

alisertib

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

Completed
  • Lung Cancer
  • Mesothelioma
  • Alisertib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 3, 2022

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Alisertib
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jun 10, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Alisertib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory

Active, not recruiting
  • Acute Megakaryoblastic Leukemia
  • +2 more
  • Alisertib
  • +2 more
  • Miami, Florida
  • +2 more
May 4, 2021

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Alisertib
  • +3 more
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Advanced Solid Tumors, Relapsed/Refractory Lymphoma Trial in United States (Alisertib, Itraconazole)

Completed
  • Advanced Solid Tumors
  • Relapsed/Refractory Lymphoma
  • Saint Louis, Missouri
  • +3 more
Aug 16, 2019

Advanced Nonhematologic Malignancies Trial in Worldwide (MLN2480, MLN0128, Alisertib)

Completed
  • Advanced Nonhematologic Malignancies
  • Boston, Massachusetts
  • +13 more
Feb 11, 2020

Advanced Solid Tumors, Lymphoma Trial in Bronx, Nashville, San Antonio (Alisertib)

Completed
  • Advanced Solid Tumors
  • Lymphoma
  • Alisertib
  • Bronx, New York
  • +2 more
Mar 26, 2019

Solid Tumors, Lymphoma Trial in United States (Alisertib, Esomeprazole, Rifampin)

Completed
  • Solid Tumors
  • Lymphoma
  • Alisertib
  • +2 more
  • Sarasota, Florida
  • +6 more
Dec 18, 2018

Bladder Cancer, Transitional Cell Carcinoma Trial in Milano (Alisertib, Paclitaxel, Placebo)

Completed
  • Bladder Cancer
  • Transitional Cell Carcinoma
  • Alisertib
  • +2 more
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 9, 2019

Advanced Solid Tumors, Lymphomas Trial in Tiong Bahru (Alisertib)

Completed
  • Advanced Solid Tumors
  • Lymphomas
  • Alisertib
  • Tiong Bahru, Singapore
    National Cancer Centre
Nov 29, 2018

Malignant Tumor of Breast, CNS Malignancy, Malignant Tumor of Gastrointestinal Tract Trial in Chicago (Alisertib, Pazopanib)

Completed
  • Malignant Neoplasm of Breast
  • +6 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Jul 18, 2019

Advanced Solid Tumors, Lymphoma Trial in Tacoma ([^14C]-alisertib, alisertib)

Completed
  • Advanced Solid Tumors
  • Lymphoma
  • Tacoma, Washington
    Comprehensive Clinical Development
Feb 20, 2018

Advanced Solid Tumors, Adenocarcinoma of the Prostate Trial in United States (Alisertib, Docetaxel)

Completed
  • Advanced Solid Tumors
  • Adenocarcinoma of the Prostate
  • Indianapolis, Indiana
  • +3 more
Oct 4, 2018

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)

Terminated
  • Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
  • Lake Success, New York
  • +5 more
Aug 19, 2019

Advanced Solid Tumors, Relapsed/Refractory Lymphoma Trial in United States (Alisertib)

Completed
  • Advanced Solid Tumors
  • Relapsed/Refractory Lymphoma
  • Alisertib
  • Miami, Florida
  • +6 more
Apr 9, 2018

Advanced Solid Tumors Trial in Santa Monica (Alisertib)

Completed
  • Advanced Solid Tumors
  • Alisertib
  • Santa Monica, California
    Premiere Oncology, A Medical Corporation
Mar 8, 2019

Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Rochester (Alisertib,

Completed
  • Estrogen Receptor Positive
  • +5 more
  • Alisertib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 2, 2018

Advanced Malignancies Trial in Nashville (Alisertib)

Completed
  • Advanced Malignancies
  • Alisertib
  • Nashville, Tennessee
    Sarah Cannon Research Institute (SCRI)
Nov 29, 2018

Advanced Malignancies Trial in Barcelona, Valencia (alisertib)

Completed
  • Advanced Malignancies
  • alisertib
  • Barcelona, Spain
  • +1 more
Nov 29, 2018

Malignant Digestive System Tumor Trial in United States (Alisertib, Fluorouracil, Laboratory Biomarker Analysis)

Completed
  • Malignant Digestive System Neoplasm
  • Alisertib
  • +4 more
  • New Haven, Connecticut
  • +4 more
Oct 5, 2018

Small Cell Lung Cancer Trial in Worldwide (Alisertib, Placebo, Paclitaxel)

Completed
  • Small Cell Lung Cancer
  • Alisertib
  • +2 more
  • Los Angeles, California
  • +60 more
Dec 3, 2018